000			01894 a2200553 4500
005			20250514031953.0
264		0	_c20021122
008			200211s 0 0 eng d
022			_a0264-410X
024	7		_a10.1016/s0264-410x(02)00089-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aGruters, Rob A
245	0	0	_aThe advantage of early recognition of HIV-infected cells by cytotoxic T-lymphocytes. _h[electronic resource]
260			_bVaccine _cMay 2002
300			_a2011-5 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAIDS Vaccines
650	0	4	_aAmino Acid Sequence
650	0	4	_aAnimals
650	0	4	_aAntigen Presentation
650	0	4	_aCytotoxicity, Immunologic
650	0	4	_aEpitopes _ximmunology
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Viral
650	0	4	_aGene Products, rev _ximmunology
650	0	4	_aGene Products, tat _ximmunology
650	0	4	_aHIV Antigens _xgenetics
650	0	4	_aHIV Infections _ximmunology
650	0	4	_aHIV Long-Term Survivors
650	0	4	_aHIV-1 _xgenetics
650	0	4	_aHLA Antigens _ximmunology
650	0	4	_aHumans
650	0	4	_aImmunity, Innate
650	0	4	_aKenya
650	0	4	_aMacaca
650	0	4	_aMice
650	0	4	_aSex Work
650	0	4	_aSimian Acquired Immunodeficiency Syndrome _ximmunology
650	0	4	_aT-Lymphocytes, Cytotoxic _ximmunology
650	0	4	_aTime Factors
650	0	4	_aViral Load
650	0	4	_aViremia _ximmunology
650	0	4	_arev Gene Products, Human Immunodeficiency Virus
650	0	4	_atat Gene Products, Human Immunodeficiency Virus
700	1		_avan Baalen, Carel A
700	1		_aOsterhaus, Albert D M E
773	0		_tVaccine _gvol. 20 _gno. 15 _gp. 2011-5
856	4	0	_uhttps://doi.org/10.1016/s0264-410x(02)00089-0 _zAvailable from publisher's website
999			_c11883519 _d11883519